Duration of the second and third stages of labor and risk of postpartum hemorrhage: a cohort study stratified by parity
- PMID: 39934771
- PMCID: PMC11817052
- DOI: 10.1186/s12884-025-07229-4
Duration of the second and third stages of labor and risk of postpartum hemorrhage: a cohort study stratified by parity
Abstract
Background: Postpartum hemorrhage (PPH) remains a leading cause of maternal morbidity and mortality worldwide. It is therefore important to improve our understanding of the risk factors for PPH according to parity, in particular, those linked to modifiable obstetric practices. The aim of this study was to assess the risk of PPH by the duration of the second and third stages of labor, stratified by parity.
Methods: This study was based on secondary analysis of data from participants in a randomized controlled trial. A sample of women from three university hospitals in France aged at least 18 years, with a singleton pregnancy, in the first stage of labor, at 36-42 weeks of gestation, with epidural anesthesia and a vaginal delivery were included. The main outcome was PPH rates, defined by blood loss > 500 mL within 2 h after delivery. Characteristics of mothers, newborns, labor, and delivery, and their relation to PPH were explored with multivariable regression models.
Results: Of 1598 women included, 864 were nulliparous and 680 parous; their respective PPH rates were 9.1% (79/864) and 7.4% (54/680) (P = 0.2), and the overall rate 8.3% (133/1598). The multivariable analysis found that PPH was associated with the durations of both oxytocin exposure (aOR 1.10, 95%CI 1.01-1.20) and the third stage of labour (aOR 1.80, 95%CI 1.37-2.38) among nulliparous women, and the PPH risk increased with both duration of the third stage (aOR 2.10, 95%CI 1.56-2.83) and history of PPH (aOR 3.02, 95%CI 1.38-6.59) among parous women.
Conclusions: The duration of oxytocin exposure was found to be a risk factor for PPH among nulliparous women as was a history of PPH among parous women. Future studies should focus on duration of third stage of labor, especially when active management of the third stage of labor (AMTSL) is routinely used.
Trial registration: The trial was registered at ClinicalTrials.gov NCT01113229.
Keywords: Parity; Postpartum hemorrhage; Risk factors; Stage of labor.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: ClinicalTrials.gov, https://clinicaltrials.gov , NCT01113229. We confirm that all methods were performed in accordance with the relevant guidelines and regulations. Consent for publication: Not Applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Use of oxytocin during early stages of labor and its effect on active management of third stage of labor.Am J Obstet Gynecol. 2011 Mar;204(3):238.e1-5. doi: 10.1016/j.ajog.2010.10.005. Epub 2010 Dec 8. Am J Obstet Gynecol. 2011. PMID: 21145034 Free PMC article. Clinical Trial.
-
Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial.Trials. 2017 Nov 15;18(1):541. doi: 10.1186/s13063-017-2269-9. Trials. 2017. PMID: 29141679 Free PMC article. Clinical Trial.
-
Intramuscular versus intravenous oxytocin for the third stage of labor after vaginal delivery to prevent postpartum hemorrhage: a meta-analysis of randomized controlled trials.Eur J Obstet Gynecol Reprod Biol. 2020 Jul;250:265-271. doi: 10.1016/j.ejogrb.2020.04.007. Epub 2020 May 12. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 32439242
-
Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage.J Obstet Gynaecol Can. 2009 Oct;31(10):980-993. doi: 10.1016/S1701-2163(16)34329-8. J Obstet Gynaecol Can. 2009. PMID: 19941729 Review.
-
Role of Prophylactic Oxytocin in the Third Stage of Labor: Physiologic Versus Pharmacologically Influenced Labor and Birth.J Midwifery Womens Health. 2017 Jul;62(4):418-424. doi: 10.1111/jmwh.12620. Epub 2017 Jul 13. J Midwifery Womens Health. 2017. PMID: 28703925 Review.
References
-
- Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A-B, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Global Health. 2014;2:e323–33. - PubMed
-
- Bateman BT, Berman MF, Riley LE, Leffert LR. The Epidemiology of Postpartum Hemorrhage in a large. Nationwide Sample Deliveries: Anesth Analgesia. 2010;110:1368–73. - PubMed
-
- Combs CA, Murphy EL, Laros RK. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol. 1991;77:69–76. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical